Related Experiment Video
Updated: Jan 28, 2026

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke
Published on: June 5, 2019
[The endothelial dysfunction in patients with arterial hypertension after old hemorrhagic stroke.]
G Kh Mirsaeva1, R A Khakimova1
1The Federal state budget educational institution of higher education "The Bashkir state medical university" of Minzdrav of Russia, 450005, Ufa, Russia.
The higher risk of development of cerebral complications in patients with arterial hypertension is related to formation of dysfunction of endothelium preventing appropriate regulation of cerebral bloodstream. The decreasing of athrombogenic characteristics of vessel wall can results in increased adhesion of thrombocytes on endothelium of wall of vessels, activation of hemostasis system and thrombosis. The purpose of the study is to establish the level of markers of dysfunction of endothelium-von Willebrand factor and tissue activator plasminogen in patients with arterial hypertension in dynamics after old hemorrhagic stroke. The sampling of examined patients consisted of 82 persons (main group) with arterial hypertension in various periods after old hemorrhagic stroke. To evaluate condition of endothelium activity of von Willebrand factor was detected using the technique of ristocetin-cofactor activity applying the reagents' set by Dade Behring (Germany). Also, the level of antigen and indicator of activity of tissue activator plasminogen was detected using immune enzyme technique ELISA Actibind t-PA applying reagents' set Technoclone (Austria). The statistical data processing was implemented by integrated software Statistica 8 for Windows (StatSoft). In patients with arterial hypertension independently of period of hemorrhagic stroke an endothelial dysfunction is detected presented by decreasing of level of tissue plasminogen activator and increasing of its activity. The increasing of activity of von Willebrand factor was established only in patients at early rehabilitation period of hemorrhagic stroke that indicates the stablecharacter of endothelial dysfunction in the given category of patients. The established disorders related to pathology of vessel wall can be characterized as prothrombotic that is a prognostically unfavorable factor and substantiates necessity of medicinal correction of detected disorders.
The higher risk of development of cerebral complications in patients with arterial hypertension is related to formation of dysfunction of endothelium preventing appropriate regulation of cerebral bloodstream. The decreasing of athrombogenic characteristics of vessel wall can results in increased adhesion of thrombocytes on endothelium of wall of vessels, activation of hemostasis system and thrombosis. The purpose of the study is to establish the level of markers of dysfunction of endothelium-von Willebrand factor and tissue activator plasminogen in patients with arterial hypertension in dynamics after old hemorrhagic stroke. The sampling of examined patients consisted of 82 persons (main group) with arterial hypertension in various periods after old hemorrhagic stroke. To evaluate condition of endothelium activity of von Willebrand factor was detected using the technique of ristocetin-cofactor activity applying the reagents' set by Dade Behring (Germany). Also, the level of antigen and indicator of activity of tissue activator plasminogen was detected using immune enzyme technique ELISA Actibind t-PA applying reagents' set Technoclone (Austria). The statistical data processing was implemented by integrated software Statistica 8 for Windows (StatSoft). In patients with arterial hypertension independently of period of hemorrhagic stroke an endothelial dysfunction is detected presented by decreasing of level of tissue plasminogen activator and increasing of its activity. The increasing of activity of von Willebrand factor was established only in patients at early rehabilitation period of hemorrhagic stroke that indicates the stablecharacter of endothelial dysfunction in the given category of patients. The established disorders related to pathology of vessel wall can be characterized as prothrombotic that is a prognostically unfavorable factor and substantiates necessity of medicinal correction of detected disorders.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension I: Introduction

